Western blot analysis of human liver tissue samples further showed a progressive increase in ATF3 protein expression across groups: from healthy obese individuals to those with metabolic‐associated fatty liver disease (MAFLD), and finally to MASH patients (Figure 9B,C). The gene discussed is ATF3; the disease is metabolic dysfunction-associated steatohepatitis.